Q&A Archives - Page 24 of 25 - PMWC Precision Medicine World Conference

Brad Gray, Nanostring Technologies: Interview Q&A

by admin | Nov 16, 2016 | Q&A, Speaker spotlights, Announcements

Q: What are some of the key components of the NanostringnCounter Analysis System? What are some of the advantages of the nCounter System over other analytical approaches? A: Our nCounter Analysis System unlocks massive amounts of biological information from tiny...

Fred C. Tenover, Cepheid: Interview Q&A

by admin | Nov 10, 2016 | Q&A, Speaker spotlights, Announcements

Q: Can you share with us your motivation and interest in antimicrobial resistance and development of rapid diagnostic methods for infectious disease? And why is this so important? A: We are fast approaching a time when antibiotics will no longer work and simple...

Randy Scott, Invitae Corporation: Interview Q&A

by admin | Nov 9, 2016 | Announcements, Q&A, Speaker spotlights

Q: Invitae wants to be the Amazon of genetic testing. What does that exactly mean and what does Invitae do that is different from other companies to achieve this? A: Invitae is proactively driving down the cost of genetic testing in order to make it more affordable...

Frederic Pla, Genomic Health: Interview Q&A

by admin | Nov 8, 2016 | Q&A, Speaker spotlights, Announcements

Q: What attracted you to join Genomic Health and what is your role? A:Genomic Health shifted the paradigm in cancer management, helping over 700,000 patients optimize their treatment decisions, and pioneering a new business model that has been followed by many...

Clive Morris, Inivata Ltd.: Interview Q&A

by admin | Oct 30, 2016 | Q&A, Speaker spotlights, Announcements

Q: What attracted you to join Inivata and what is your role? Chief Medical Officer, CMO A: I was attracted to Inivata to help progress a technology I see can make a major impact in improving how we diagnose and manage patients with cancer. The field of liquid biopsy,...

Lincoln Nadauld, Intermountain Healthcare: Interview Q&A

by Tal Behar | Oct 29, 2016 | Announcements, Q&A, Speaker spotlights

Q: What were the motivations to create the Oncology Precision Network (OPeN)? A: As we began implementing precision oncology at our hospitals and clinics throughout Intermountain Healthcare, we quickly began to realize that there are certain variants or mutations in a...

« Older Entries

Next Entries »

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.

We hate spam too, unsubscribe at any time.

Do not alert me again.